Objectives
To investigate the association between hearing loss, hearing aid use, and cognitive decline.
Design
Prospective population‐based study.
Setting
Data gathered from the Personnes Agées QUID ...study, a cohort study begun in 1989–90.
Participants
Individuals aged 65 and older (N = 3,670).
Measurements
At baseline, hearing loss was determined using a questionnaire assessing self‐perceived hearing loss; 137 subjects reported major hearing loss, 1,139 reported moderate problems (difficulty following the conversation when several persons talk at the same time or in a noisy background), and 2,394 reported no hearing trouble. Cognitive decline was measured using the Mini‐Mental State Examination (MMSE), administered at follow‐up visits over 25 years.
Results
Self‐reported hearing loss was significantly associated with lower baseline MMSE score (β = −0.69, P < .001) and greater decline during the 25‐year follow‐up period (β = −0.04, P = .01) independent of age, sex, and education. A difference in the rate of change in MMSE score over the 25‐year follow‐up was observed between participants with hearing loss not using hearing aids and controls (β = −0.06, P < .001). In contrast, subjects with hearing loss using a hearing aid had no difference in cognitive decline (β = 0.07, P = .08) from controls.
Conclusion
Self‐reported hearing loss is associated with accelerated cognitive decline in older adults; hearing aid use attenuates such decline.
Dementia prevention research has progressed rapidly in recent years, with publication of several large lifestyle intervention trials, and renewed interest in pharmacological interventions, notably ...for individuals with Alzheimer’s disease biomarkers, warranting an updated review of results and methodology. We identified 112 completed trials testing the efficacy of single-domain pharmacological (n = 33, 29%), nutritional (n = 27, 24%), physical activity (n = 18, 16%) and cognitive stimulation (n = 13, 12%), or multidomain (n = 22, 20%) interventions on incident dementia, or a relevant intermediate marker (e.g. cognitive function, biomarkers or dementia risk scores) in people without dementia. The earliest trials tested pharmacological interventions or nutritional supplements, but lifestyle interventions predominated in the last decade. In total, 21 (19%) trials demonstrated a clear beneficial effect on the pre-specified primary outcome (or all co-primary outcomes), but only two (10%) were large-scale (testing blood pressure lowering (Syst-Eur) or multidomain (FINGER) interventions on incident dementia and cognitive change in cognitive function, respectively). Of the 116 ongoing trials, 40% (n = 46) are testing multidomain interventions. Recent methodological shifts concern target populations, primary outcome measures, and intervention design, but study design remains constant (parallel group randomised controlled trial). Future trials may consider using adaptive trials or interventions, and more targeted approaches, since certain interventions may be more effective in certain subgroups of the population, and at specific times in the life-course. Efforts should also be made to increase the representativeness and diversity of prevention trial populations.
•Over 110 prevention trials have now been published, but many were small-scale.•Pharmacological and lifestyle interventions have been tested; most showed no effect.•2 large trials (testing multidomain or blood pressure interventions) were positive.•Ongoing trials are notably testing multidomain interventions and anti-amyloid drugs.•Methodological shifts concern target populations, endpoints and intervention design.
The proportion of persons aged 85 and over, the so-called "oldest old", is increasing dramatically worldwide. While a quarter of this population is affected by dementia, little is known about the ...specific features of cognitive functioning in the oldest old. In the presence of clinical specificities such as numerous comorbidities, multi-medication and visual and/or auditory loss, which are very frequent in extreme old age, neuropsychological assessment can be particularly challenging. This article presents an overview of the epidemiology of cognitive functioning in the oldest old, and discusses the issues regarding neuropsychological assessment and dementia in this specific elderly population.
Purpose: Dementia and cardio-metabolic diseases share many risk factors. Management of these risk factors could contribute to successful aging, including the prevention of cardio-metabolic disease ...and dementia. The increasing use of smartphones offers an opportunity for remote preventive interventions. We provided a systematic review of telephone and smartphone-based interventions targeting the prevention of cognitive decline, dementia cardio-metabolic diseases or their risk factors among adults aged over 50 years. Patients and Methods: We searched Pubmed and the International Clinical Trials Registry Platform for experimental studies. We used the Cochrane risk-of-bias tool (Version 2) for randomized trials or TREND (Transparent Reporting of Evaluations with Nonrandomized Designs) checklists to assess study quality for completed studies. Results: We analyzed 21 completed (3 for cognition, 18 for cardio-metabolic outcomes) and 50 ongoing studies (23 for cognition, 27 for cardio-metabolic outcomes). Smartphone interventions were used in 26 studies (3 completed, 23 ongoing). Other interventions involved telephone vocal support and text messaging. Few studies were at low risk of bias. There were heterogeneous cognitive and cardio-metabolic outcomes. The highest quality studies found no significant effects on cognition, and inconsistent results for HbA1c, blood pressure or physical activity. The lower quality-studies found effects on global cognition, working memory, memory and language and inconsistent results for clinical, biological or behavioral cardio-metabolic outcomes. Conclusion and Implications: Despite the large number of commercially available mobile health applications, the magnitude of the scientific evidence base remains very limited. Based on published studies, the added value of telephone and smartphone tools for the prevention of cardio-metabolic diseases, cognitive decline or dementia is currently uncertain, but, there are several ongoing studies expected to be completed in the coming years. Keywords: aging, telephone, smartphone, cognition, dementia, cardio, vascular outcomes
Alors que les personnes âgées de 80 ans et plus (oldest old dans la littérature anglophone) constituent un segment de la population de plus en plus important dans le monde et que l’âge est le ...principal facteur de risque de démence, peu d’études se sont intéressées à la cognition et à la démence dans cette population. Le premier objectif de cette thèse a été de synthétiser les données épidémiologiques et neuropsychologiques relatives aux oldest old dans le cadre du vieillissement normal et de la démence. Le manque de connaissances, d’outils et de normes adaptées pour les oldest old font de l’évaluation neuropsychologique un véritable challenge. Ainsi, dans un deuxième travail, nous avons développé des normes pour sept tests neuropsychologiques communément utilisés en clinique, administrés auprès d’une population de sujets très âgés. Néanmoins, les outils habituellement utilisés présentent des contraintes pour les très âgés qui peuvent remettre en cause leur fiabilité. Le Test des Neuf Images du 93 (TNI-93) - test évaluant la mémoire épisodique initialement développé pour les sujets de bas niveau d’étude - comporte de nombreux avantages eu égard aux spécificités cliniques des oldest old. Dans un troisième travail, nous avons cherché à étudier l’utilité du TNI-93 chez les oldest old en établissant des normes puis en étudiant ses propriétés de détection de la démence dans cette population. L’ensemble de ces travaux pourrait contribuer à améliorer la prise de décision diagnostique dans cette population, même s’il convient de souligner l’importance de promouvoir la recherche dans ce domaine pour comprendre les enjeux cliniques et neuropsychologiques du très grand âge.
While persons aged 80 years and over, the so-called “oldest old”, constitute the fastest growing segment of the population worldwide and age is the major risk factor for developing dementia, only few studies have addressed cognition and dementia in this population. The first objective of this thesis was to review the epidemiological and neuropsychological data relating to oldest old in the context of normal aging and dementia. The lack of knowledge, tools and normative data for oldest old make neuropsychological assessment a real challenge for clinicians. For this reason, the second step consisted in computing normative data for seven neuropsychological tests commonly used in clinical practice collected in an oldest old population. Likewise, the tools generally used in older adults testing involve constraints that question the reliability of the measurement. The “Test des Neuf Images of the 93” (TNI-93), (meaning Nine Images test of the district of Seine-Saint-Denis in the suburb of Paris) - test evaluating episodic memory initially developed for low-educational level subjects - could deal with the testing difficulties due to clinical specificities of oldest old. Thus, in a third work, we assessed the relevance of TNI-93 in oldest old by providing normative data, and also by studying its dementia detection properties in this specific population. Taken together, these works may contribute to improve decision-making diagnosis in oldest old population even though it is necessary to underline the importance of promoting research in this domain to deal with the clinical and neuropsychological challenges of the very old age.
There is an obvious lack of validated norms for elderly persons aged 85 and older for the large majority of the neuropsychological tests used in clinical practice. Yet this range of "oldest-old" ...individuals drastically increases worldwide and is the more likely to develop dementia. Providing clinicians validated and updated norms to accurately evaluate cognitive functioning in this population is an important issue in geriatrics. This study provides normative scores for 7 neuropsychological tests commonly used in clinical practice. Data were collected in a sample of 283 subjects aged 85 and older, included in the PAQUID study, a population-based cohort conducted in France. Normative scores were calculated according to 2 age ranges and 2 educational levels, and are presented in percentiles. The norms provided in the present study involve 7 tests that are widely used in the neuropsychological assessment of geriatrics populations and should be of help for clinicians.
PDF